C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/517 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2752114
The present invention relates to compounds of formula (I), a N-oxide or tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6, R7, R10, m and n have the meanings as given in the description and the claims, which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.
La présente invention concerne des composés de formule (I), un N-oxyde ou un tautomère ou un stéréo-isomère de ces composés, ou un sel de ceux-ci, où le cycle B et l'imidazole avec lequel il est condensé, R4, R6, R7, R10, m et n ont les significations telles que données dans la description et les revendications, qui sont des inhibiteurs efficaces de la voie Pi3K/Akt, des procédés pour leur production et leur utilisation en tant qu'agents pharmaceutiques.
Baer Thomas
Beckers Thomas
Beneke Gerrit
Boemer Ulf
Dehmel Florian
Bayer Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Fused pyrimidines as akt inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused pyrimidines as akt inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused pyrimidines as akt inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1706646